Hemab Therapeutics Holdings, Inc. Common Stock (COAG) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $57.5M, listed on NASDAQ, employing roughly 59 people, carrying a beta of 0.00 to the broader market. Hemab Therapeutics Holdings, Inc. Led by Benny Sorensen, public since 2026-05-01.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for COAG as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →